Search

The article reflects on the study which concentrates on the efficacy of an atypical antipsychotic for treatment resistant behaviour. It states that the study failed to provide the data with patient's baseline characteristics and the results from individual trials. It argues that the findings of the study is more effective in terms of response and remission. It suggests the need of a careful analysis in drawing the conclusion with the research.

Over 25% of people with schizophrenia, psychoses, or severe mental disorders fail to adhere to treatment programmes. People with schizophrenia, psychoses, or severe mental disorders were taken for the study ; participant recruitment in a psychiatric setting and treatment adherence, is considered as primary outcome measure. Studies set in general medical wards and emergency rooms, studies on compulsory treatment, and studies examining adherence to initial psychiatry appointments. The overall weighted mean rate of non-adherence was 25.78%. Patients most associated with non-adherence were young males with a historv of substance abuse, low social functioning, unemployment or with limited insight into their illness.

Determines the beneficial and adverse effects of low dose tricyclic antidepressants for adults with acute phase depression. Design of the study; Data sources; Study selection; Data extraction; Evidence that people receiving low dose tricyclics were more likely to respond to treatment at four weeks compared to placebo.